Ocular Tuberculosis

  • Arzu Taskiran Comez


Periocular or intraocular infection mainly by Mycobacterium species is defined as “ocular tuberculosis” (ocular TB), which mainly occurs by hematogenous dissemination of the pulmonary and extrapulmonary TB. The most common clinical presentation of ocular tuberculosis is uveitis, with posterior uveitis being the most common followed by anterior uveitis, panuveitis, and intermediate uveitis.

Definitive diagnosis may be achieved by examination of smears and staining for acid-fast organisms and cultures of intraocular tissue/fluid for Mycobacterium tuberculosis.

The current treatment of intraocular TB consists of use of isoniazid, rifampicin, ethambutol, and pyrazinamide for a long period of time.

Since ocular TB is a masquerading disease with different clinical manifestations, with no gold standard test for a certain diagnosis, an empirical clinical approach, including ocular and systemic examination, laboratory testing of the bacillus in the intraocular fluids and tissues by direct microscopy, culture, or PCR, is needed to make a definitive diagnosis.


Eye Tuberculosis Ocular tuberculosis Uveitis Mycobacterium tuberculosis Posterior uveitis Acid-fast staining Iridocyclitis Choroiditis Extrapulmonary tuberculosis 


  1. 1.
    Shakarchi FI. Ocular tuberculosis: current perspectives. Clin Ophthalmol. 2015;9:2223–7. Scholar
  2. 2.
    Jabbar A, Khan J, Ullah A, Rehman H, Ali I. Detection of Mycobacterium tuberculosis and Mycobacterium bovis from human sputum samples through multiplex PCR. Pak J Pharm Sci. 2015;28(4):1275–80.PubMedGoogle Scholar
  3. 3.
    Biswas J, Badrinath SS. Ocular morbidity in patients with active systemic tuberculosis. Int Ophthalmol. 1995–1996;19:293–8.CrossRefGoogle Scholar
  4. 4.
    Abu El-Asrar AM, Abouammoh M, Al-Mezaine HS. Tuberculous uveitis. Middle East Afr J Ophthalmol. 2009;16(4):188–201. Scholar
  5. 5.
    Woods AC. Modern concepts of the etiology of uveitis. Am J Ophthalmol. 1960;50:1170–87.CrossRefGoogle Scholar
  6. 6.
    Samson MC, Foster CS. Tuberculosis. In: Foster CS, Vitale AT, editors. Diagnosis and treatment of uveitis. Philadelphia: WB Saunders Company; 2002. p. 264–72.Google Scholar
  7. 7.
    Woods AC, Abrahams IW. Uveitis survey sponsored by the American Academy of Ophthalmology and Otolaryngology. Am J Ophthalmol. 1961;51:761–80.CrossRefGoogle Scholar
  8. 8.
    Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103:131–6.CrossRefGoogle Scholar
  9. 9.
    Donahue HC. Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol. 1967;64:742–8.CrossRefGoogle Scholar
  10. 10.
    Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173–83.CrossRefGoogle Scholar
  11. 11.
    Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al. Clinical patterns and characteristics of uveitis in a tertiary canter for uveitis in China. Curr Eye Res. 2005;30:943–8.CrossRefGoogle Scholar
  12. 12.
    Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;52:121–5.PubMedGoogle Scholar
  13. 13.
    Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing pattern of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11:277–86.CrossRefGoogle Scholar
  14. 14.
    Norn M. [Ophthalmic tuberculosis, especially in Denmark]. Dan Medicinhist Arbog. 2001;212–8.Google Scholar
  15. 15.
    Khokkanen VM, Iagafarova RK. Clinical and epidemiological characteristics of patients with eye tuberculosisProbl Tuberk. 1998;6:14–5.Google Scholar
  16. 16.
    Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15:285–93.CrossRefGoogle Scholar
  17. 17.
    Alvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore). 1984;63(1):25–55.CrossRefGoogle Scholar
  18. 18.
    Al-Shakarchi F. Mode of presentations and management of presumed tuberculous uveitis at a referral center. Iraqi Postgrad Med J. 2015;14(1):91–5.Google Scholar
  19. 19.
    Gupta V, Gupta A, Rao NA. Intraocular tuberculosis-an update. Surv Ophthalmol. 2007;52:561–87.CrossRefGoogle Scholar
  20. 20.
    Helm CJ, Holland GN. Ocular tuberculosis. Surv Ophthalmol. 1993;38:229–56.CrossRefGoogle Scholar
  21. 21.
    Bodaghi B, LeHoang P. Ocular tuberculosis. Curr Opin Ophthalmol. 2000;11:443–8.CrossRefGoogle Scholar
  22. 22.
    Ray S, Gragoudas E. Neuroretinitis. Int Ophthalmol Clin. 2001;41:83–102.CrossRefGoogle Scholar
  23. 23.
    Slavin RE, Walsh TJ, Pollack AD. Late generalized tuberculosis: a clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras. Medicine (Baltimore). 1980;59:352–66.CrossRefGoogle Scholar
  24. 24.
    Varma D, Anand S, Reddy AR, et al. Tuberculosis: an under-diagnosed aetiological agent in uveitis with an effective treatment. Eye (Lond). 2006;20:1068–73.CrossRefGoogle Scholar
  25. 25.
    Feng Y, Diao N, Shao L, et al. Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis. Chabalgoity JA, ed. PLoS One. 2012;7(3):e32652. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Ang M, Wong W, Ngan CC, Chee SP. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye. 2012;26(5):658–65.CrossRefGoogle Scholar
  27. 27.
    Gupta A, Gupta V. Tubercular posterior uveitis. Int Ophthalmol Clin. 2005;45:71–88.CrossRefGoogle Scholar
  28. 28.
    Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):7–13. Scholar
  29. 29.
    Onal S, Tutkun IT. Ocular tuberculosis I: epidemiology, pathogenesis and clinical features. Turk J Ophthalmol. 2011;41:171–81.CrossRefGoogle Scholar
  30. 30.
    Onal S, Tutkun IT. Ocular tuberculosis II: diagnosis and treatment. Turk J Ophthalmol. 2011;41:182–90.CrossRefGoogle Scholar
  31. 31.
    Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008;146:772–9.CrossRefGoogle Scholar
  32. 32.
    Centers for Disease Control and Prevention (CDC); American Thoracic Society. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:735–9.Google Scholar
  33. 33.
    Bıçakcı F, Ozeren A, Yerdelen D, Sarica Y. Etambutol kullanımına bağlı optik nöropati. Turkiye Klinikleri J Med Sci. 2005;25:460–2.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Arzu Taskiran Comez
    • 1
  1. 1.Canakkale Onsekiz Mart University, School of Medicine, Department of OphthalmologyCanakkaleTurkey

Personalised recommendations